Avitide Overview
- Founded
-
2012

- Status
-
Acquired/Merged
- Employees
-
34

- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$275M
Avitide General Information
Description
Developer a molecule-specific affinity purification technology designed to improve drug safety and establish bio similarity. The company's technology focuses on purifying therapeutic proteins, and uses rapid development of chromatography resins via chemical synthesis, enabling partners to achieve speeded bioprocess development timelines, reduced program risk, predictable commercial scalability, and lower cost of manufacturing for batch and continuous operations.
Contact Information
Website
www.avitide.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Parent Company
Primary Office
- 16 Cavendish Court
- Lebanon, NH 03766
- United States
+1 (603) 000-0000
Avitide Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
9. Merger/Acquisition | 30-Sep-2021 | $275M | 000.00 | 00000 | Completed | Generating Revenue |
8. Later Stage VC (Series H) | 23-Oct-2019 | 0000 | 000.00 | 00000 | Completed | Generating Revenue |
7. Later Stage VC (Series G) | 23-Aug-2018 | 00.000 | 000.00 | 00000 | Completed | Generating Revenue |
6. Later Stage VC (Series F) | 02-Jan-2018 | 000 | 000.00 | 00000 | Completed | Generating Revenue |
5. Later Stage VC (Series E) | 26-Jun-2017 | 0000 | 000.00 | 0000 | Completed | Generating Revenue |
4. Later Stage VC (Series D) | 12-Sep-2016 | 000 | 000.00 | 000.00 | Completed | Generating Revenue |
3. Later Stage VC (Series C) | 06-Aug-2015 | 00.00 | 000.00 | 000.00 | Completed | Generating Revenue |
2. Early Stage VC (Series B) | 09-Jun-2014 | $3.44M | $4.89M | 000.00 | Completed | Startup |
1. Early Stage VC (Series A) | 04-Mar-2013 | $1.45M | $1.45M | 00.000 | Completed | Startup |
Avitide Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series H | 000,000 | 00.000000 | 000.00 | 000.00 | 00 | 000.00 | 0.000 | |
Series G | 000,000 | 00.000000 | 000.00 | 000.00 | 00 | 000.00 | 0.000 | |
Series F | 000,000 | 00.000000 | 000.00 | 000.00 | 00 | 000.00 | 0.000 | |
Series E | 000,000 | 00.000000 | 000.00 | 000.00 | 00 | 000.00 | 00.000 | |
Series D | 000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 0.000 | |
Series C | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 00.000 | |
Series B | 918,450 | $0.000100 | $3.74 | $3.74 | 1x | $3.74 | 10.92% | |
Series A | 783,422 | $0.000100 | $1.87 | $1.87 | 1x | $1.87 | 9.32% |
Avitide Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Developer a molecule-specific affinity purification technology designed to improve drug safety and establish bio similar
Biotechnology
Lebanon, NH
34
As of 2021
000.00
0000
0000-00-00
000000&0
000.00
Avitide Competitors (28)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
ToolGen | Corporation | Seoul, South Korea | 00 | 0000 | 0000000000 0 | 0000 |
00000000 000000000 | Formerly VC-backed | Fremont, CA | 000 | 000.00 | 000000&0 | 000.00 |
000000 00000000000 | Formerly VC-backed | Zug, Switzerland | 000 | 00000 | 000000000 | 00000 |
000000 00000000 | Venture Capital-Backed | Cambridge, United Kingdom | 00 | 000.00 | 0000000000 0 | 000.00 |
0000000000 | Venture Capital-Backed | South San Francisco, CA | 00 | 000.00 | 0000000000 0 | 000.00 |
Avitide Executive Team (8)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Kevin Isett Ph.D | Co-Founder & Chief Executive Officer | ||
Scott Kennedy | Vice President & Chief Financial Officer | ||
Warren Kett Ph.D | Co-Founder & Chief Scientific Officer | ||
Errik Anderson | Co-Founder | ||
Tillman Gerngross Ph.D | Co-Founder |
Avitide Signals
Avitide Former Investors (12)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Angeli Parvi | Angel Group | Minority | 000 0000 | 000000 0 | |
Borealis Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
Hoyoung Huh | Angel (individual) | Minority | 000 0000 | 000000 0 | |
John Ballard | Angel (individual) | Minority | 000 0000 | 000000 0 | |
Mithril Capital Management | Venture Capital | Minority | 000 0000 | 000000 0 |